This inventor holds 1 USPTO granted patent. Top assignee: Ams Research Corporation. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Edward Luttich: Innovator in Incontinence Treatment
Introduction
Edward Luttich is a notable inventor based in Dublin, California. He has made significant contributions to the field of medical technology, particularly in the treatment of incontinence. His innovative approach focuses on enhancing the safety and efficacy of treatment methodologies.
Latest Patents
Luttich holds a patent for "Endo-pelvic fascia penetrating heating systems and methods for incontinence treatment." This patent describes retrograde methods of accessing and treating collagenous pelvic tissue from a fixed point behind the endo-pelvic fascia. The treatment is performed from the space of Retzius, which allows for simple and reliable placement and application of the system. This innovation enhances both the safety and efficacy of retrograde methodologies. The systems comprise at least a two-part assembly, including a penetrating cannula or trocar and an expansible energy applying applicator. These systems are particularly well-suited for treating incontinence and other conditions related to insufficient collagenous pelvic tissue support.
Career Highlights
Luttich is associated with Ams Research Corporation, where he continues to develop and refine his innovative medical technologies. His work has been instrumental in advancing treatment options for patients suffering from incontinence.
Collaborations
Luttich collaborates with Terry E. Spraker, contributing to the development of effective medical solutions.
Conclusion
Edward Luttich's contributions to medical technology, particularly in the treatment of incontinence, highlight his innovative spirit and dedication to improving patient care. His patent reflects a significant advancement in the field, showcasing the potential for enhanced treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
